Literature DB >> 15174907

Endovascular stenting for stenoses in surgically reconstructed brachiocephalic bypass grafts: immediate and midterm outcomes.

Angelo Anzuini1, Roberto Chiesa, Krishnamoorthy Vivekananthan, Barry Uretsky, Antonio Colombo, Alberto Margonato, Flavio Airoldi, Salvatore Rosanio, Giuseppe Augello, Yochai Birnbaum, Giuseppe Magnani, Gloria Esposito, Germano Melissano, Marcelo R L Moura, Carlo Briguori.   

Abstract

PURPOSE: To report the use of endovascular stenting for treatment of patients with symptomatic obstruction of brachiocephalic surgical reconstructions.
METHODS: Twenty-two patients (17 men; mean age 65+/-6 years) with 24 symptomatic obstructions of brachiocephalic Dacron bypass grafts (2 aorto-innominate, 9 subclavian-carotid, and 11 carotid-subclavian) were treated with balloon-expandable stents delivered via a percutaneous brachial access or surgical exposure of the common carotid artery. A distal protection device was utilized in the 9 patients with subclavian-carotid bypass grafts. All patients were followed by clinical and Doppler examinations.
RESULTS: Procedural success was 100%; 1 (4.5%) patient developed transient intraprocedural aphasia owing to intolerance to the distal protection balloon occlusion. All 22 patients reported complete relief of their presenting symptoms. Over a 29-month follow-up, 3 (13.6%) restenoses were found, but none was due to stent compression.
CONCLUSIONS: Stenting for obstructed brachiocephalic reconstructions appears to be a safe, effective, and durable therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15174907     DOI: 10.1583/03-1111.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  1 in total

1.  Acutely Symptomatic Hypoperfusion Through an Occluded Subclavian to Internal Carotid Artery Bypass Graft: Salvage Mechanical Thrombectomy and Graft Revascularization.

Authors:  Jose Marino Granados; Anna Luisa Kuhn; Ajit S Puri; Francesco Massari; Jasmeet Singh
Journal:  Cureus       Date:  2022-01-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.